DK1578406T3 - Farmaceutisk sammensætning med modificeret frigivelse - Google Patents
Farmaceutisk sammensætning med modificeret frigivelseInfo
- Publication number
- DK1578406T3 DK1578406T3 DK03777508T DK03777508T DK1578406T3 DK 1578406 T3 DK1578406 T3 DK 1578406T3 DK 03777508 T DK03777508 T DK 03777508T DK 03777508 T DK03777508 T DK 03777508T DK 1578406 T3 DK1578406 T3 DK 1578406T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- modified release
- release pharmaceutical
- coated
- granulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200318A SI21349A (sl) | 2002-12-24 | 2002-12-24 | Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine |
SI200300246A SI21602A (sl) | 2003-09-24 | 2003-09-24 | Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine |
PCT/SI2003/000048 WO2004058230A1 (en) | 2002-12-24 | 2003-12-23 | Modified release pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1578406T3 true DK1578406T3 (da) | 2008-09-08 |
Family
ID=32684373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03777508T DK1578406T3 (da) | 2002-12-24 | 2003-12-23 | Farmaceutisk sammensætning med modificeret frigivelse |
Country Status (15)
Country | Link |
---|---|
US (1) | US7485322B2 (es) |
EP (1) | EP1578406B1 (es) |
AT (1) | ATE396712T1 (es) |
AU (1) | AU2003286994A1 (es) |
BR (1) | BRPI0317682B1 (es) |
CA (1) | CA2509976C (es) |
DE (1) | DE60321386D1 (es) |
DK (1) | DK1578406T3 (es) |
EA (1) | EA011373B1 (es) |
ES (1) | ES2305537T3 (es) |
MX (1) | MXPA05006916A (es) |
PL (1) | PL207776B1 (es) |
PT (1) | PT1578406E (es) |
SI (1) | SI1578406T1 (es) |
WO (1) | WO2004058230A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6607751B1 (en) * | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) * | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US9463426B2 (en) * | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US20190083399A9 (en) * | 2006-04-03 | 2019-03-21 | Isa Odidi | Drug delivery composition |
EP2007360B1 (en) * | 2006-04-03 | 2014-11-26 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
PL216542B1 (pl) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
WO2011017389A1 (en) | 2009-08-05 | 2011-02-10 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
CA2784748A1 (en) | 2009-12-18 | 2011-06-23 | Idenix Pharmaceuticals, Inc. | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
CA2809983A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Hydrobromide salts of a pyrazolylaminoquinazoline |
JP5932794B2 (ja) | 2010-09-01 | 2016-06-08 | アムビト ビオスシエンセス コルポラチオン | 光学活性のあるピラゾリルアミノキナゾリン及びその医薬組成物及び使用方法 |
EP2648676A4 (en) | 2010-12-06 | 2016-05-04 | Follica Inc | METHODS FOR TREATING CALVITIA AND PROMOTING HAIR GROWTH |
WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
CN103338753A (zh) | 2011-01-31 | 2013-10-02 | 细胞基因公司 | 胞苷类似物的药物组合物及其使用方法 |
TW201309690A (zh) | 2011-02-10 | 2013-03-01 | Idenix Pharmaceuticals Inc | 巨環絲胺酸蛋白酶抑制劑,其醫藥組合物及其於治療hcv感染之用途 |
US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
EP2765998A1 (en) | 2011-10-11 | 2014-08-20 | Ranbaxy Laboratories Limited | A gastroretentive dosage system and process of preparation thereof |
SG10201507714XA (en) | 2012-03-16 | 2015-10-29 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
WO2015042375A1 (en) | 2013-09-20 | 2015-03-26 | Idenix Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
US20170066779A1 (en) | 2014-03-05 | 2017-03-09 | Idenix Pharmaceuticals Llc | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
WO2015143161A1 (en) | 2014-03-20 | 2015-09-24 | Capella Therapeutics, Inc. | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
PT3119762T (pt) | 2014-03-20 | 2021-08-31 | Capella Therapeutics Inc | Derivados de benzimidazole como inibidores de tirosina quinase erbb para o tratamento do cancro |
CN107250116B (zh) | 2014-12-23 | 2020-10-27 | 艾士盟医疗公司 | 3,5-二氨基吡唑激酶抑制剂 |
CN107007838B (zh) * | 2016-09-30 | 2021-07-20 | 南京优科制药有限公司 | 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物 |
CN113768898A (zh) * | 2021-09-14 | 2021-12-10 | 江苏万邦生化医药集团有限责任公司 | 悬浮的胶囊片 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1815902A (en) * | 1927-07-16 | 1931-07-28 | Nat Aniline & Chem Co Inc | Device for administering medicaments |
US2340037A (en) * | 1941-09-08 | 1944-01-25 | Zipper Alfred Irving | Capsule |
US3186910A (en) * | 1962-03-08 | 1965-06-01 | Jacob A Glassman | Method for producing peroral capsules |
JPS5512411B2 (es) * | 1974-03-12 | 1980-04-02 | ||
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4601896A (en) * | 1984-03-21 | 1986-07-22 | Mark Nugent | Pharmaceutical capsule compositions and structures for gastric sensitive materials |
DE3627423A1 (de) | 1986-08-13 | 1988-02-18 | Thomae Gmbh Dr K | Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
US5002772A (en) * | 1988-05-31 | 1991-03-26 | Pfizer Inc. | Gastric retention system for controlled drug release |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5387421A (en) * | 1991-01-31 | 1995-02-07 | Tsrl, Inc. | Multi stage drug delivery system |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
US5169638A (en) * | 1991-10-23 | 1992-12-08 | E. R. Squibb & Sons, Inc. | Buoyant controlled release powder formulation |
US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
JP2959423B2 (ja) | 1994-12-01 | 1999-10-06 | シオノギクオリカプス株式会社 | カプセル用皮膜組成物 |
TW550090B (en) | 1997-05-09 | 2003-09-01 | Sage Pharmaceuticals Inc | Stable oral pharmaceutical dosage forms for acid-unstable drug |
CN100358509C (zh) * | 1998-09-28 | 2008-01-02 | 沃纳-兰伯特公司 | 采用hpmc胶囊进行肠和结肠传递 |
NZ516733A (en) * | 1999-07-30 | 2004-03-26 | Smithkline Beecham Plc | Pharmaceutical formulations for oral dosing that are dosage forms comprising two or more connected sub-units |
US7674480B2 (en) | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US20030194430A1 (en) * | 2002-04-10 | 2003-10-16 | Miller Frederick H. | Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions |
-
2003
- 2003-12-18 US US10/740,208 patent/US7485322B2/en not_active Expired - Fee Related
- 2003-12-23 MX MXPA05006916A patent/MXPA05006916A/es active IP Right Grant
- 2003-12-23 SI SI200331331T patent/SI1578406T1/sl unknown
- 2003-12-23 PT PT03777508T patent/PT1578406E/pt unknown
- 2003-12-23 AU AU2003286994A patent/AU2003286994A1/en not_active Abandoned
- 2003-12-23 BR BRPI0317682-7A patent/BRPI0317682B1/pt not_active IP Right Cessation
- 2003-12-23 ES ES03777508T patent/ES2305537T3/es not_active Expired - Lifetime
- 2003-12-23 DK DK03777508T patent/DK1578406T3/da active
- 2003-12-23 AT AT03777508T patent/ATE396712T1/de active
- 2003-12-23 CA CA2509976A patent/CA2509976C/en not_active Expired - Fee Related
- 2003-12-23 PL PL376099A patent/PL207776B1/pl unknown
- 2003-12-23 EP EP03777508A patent/EP1578406B1/en not_active Expired - Lifetime
- 2003-12-23 WO PCT/SI2003/000048 patent/WO2004058230A1/en not_active Application Discontinuation
- 2003-12-23 EA EA200500909A patent/EA011373B1/ru not_active IP Right Cessation
- 2003-12-23 DE DE60321386T patent/DE60321386D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20040131669A1 (en) | 2004-07-08 |
MXPA05006916A (es) | 2005-08-18 |
US7485322B2 (en) | 2009-02-03 |
EA200500909A1 (ru) | 2006-02-24 |
BRPI0317682B1 (pt) | 2015-04-14 |
EP1578406B1 (en) | 2008-05-28 |
PT1578406E (pt) | 2008-09-01 |
ES2305537T3 (es) | 2008-11-01 |
PL207776B1 (pl) | 2011-01-31 |
PL376099A1 (en) | 2005-12-12 |
AU2003286994A1 (en) | 2004-07-22 |
WO2004058230A1 (en) | 2004-07-15 |
EP1578406A1 (en) | 2005-09-28 |
DE60321386D1 (de) | 2008-07-10 |
BR0317682A (pt) | 2005-11-29 |
CA2509976C (en) | 2012-03-13 |
ATE396712T1 (de) | 2008-06-15 |
SI1578406T1 (sl) | 2009-02-28 |
CA2509976A1 (en) | 2004-07-15 |
EA011373B1 (ru) | 2009-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1578406T3 (da) | Farmaceutisk sammensætning med modificeret frigivelse | |
PT1439829E (pt) | Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa | |
MXPA03007712A (es) | Sales farmaceuticas. | |
EA200501586A1 (ru) | Фармацевтические продукты | |
IL163552A (en) | Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same | |
WO2004058837A3 (de) | Ampholytisches copolymer und dessen verwendung | |
HUP0402280A2 (hu) | Mikronizált filmképző por, az ezt tartalmazó készítmények, eljárások ezek előállítására, és ezek alkalmazása | |
SI1532149T1 (sl) | amino piperidin il ksantini njihova priprava in njihova uporaba kot zdravila | |
WO2007010034A3 (de) | Ampholytisches copolymer, dessen herstellung und verwendung | |
BR0314356A (pt) | Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas | |
IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
IL163866A0 (en) | 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient | |
DE60205749D1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
AU2003211951A1 (en) | N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient | |
AR033711A1 (es) | Composiciones farmaceuticas | |
ATE363896T1 (de) | Gegen missbrauch gesicherte darreichungsform | |
EP1731609A4 (en) | INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF | |
WO2005007137A3 (de) | Ambroxolhaltige tabletten | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
ECSP066872A (es) | Tabletas desintegrantes que comprenden licarbazepina | |
BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
ATE286894T1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
MXPA01008348A (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
WO2004024128A3 (en) | Modified release ketoprofen dosage form | |
EA200100802A1 (ru) | Применение тианептина при приготовлении лекарственных средств, предназначенных для лечения нейродегенеративных патологий |